On September 8, 2022, Photys Therapeutics, Inc. closed the transaction. The round of funding led by MPM Asset Management, L.L.C.. The transaction included participation from Omega Fund Management, LLC, Longwood Fund, 8VC, Arkin Bio Venture Partners Ltd., Mass General Brigham Ventures, LLC, MRL Ventures Fund, Merck Global Health Innovation Fund, LLC, Eli Lilly and Company , Heritage Medical Systems, Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
735 USD | -2.77% | +0.20% | +26.08% |
05-03 | News Highlights : Top Company News of the Day - Friday at 5 PM ET | DJ |
05-03 | News Highlights : Top Company News of the Day - Friday at 7 PM ET | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Photys Therapeutics, Inc. announced that it has received $75.000001 million in funding from a group of investors